Literature DB >> 17304625

Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3.

Hyun-Dong Chang1, Christina Helbig, Lars Tykocinski, Stephan Kreher, Juliana Koeck, Uwe Niesner, Andreas Radbruch.   

Abstract

In Th1 and Th2 memory lymphocytes, the genes for the cytokines interleukin (IL)-4 and interferon-gamma (IFN-gamma) are imprinted for expression upon restimulation. This cytokine memory is based on expression of the transcription factors T-bet for IFN-gamma, and GATA-3 for IL-4, and epigenetic modification of the cytokine genes. In Th2 cells, expression of the cytokine IL-10 is also induced by GATA-3. Here, we show that this induction is initially not accompanied by epigenetic modification of the IL-10 gene. Only after repeated restimulation of a memory Th2 cell in the presence of IL-4, extensive histone acetylation of the IL-10 gene is detectable. This epigenetic imprinting correlates with the development of a memory for IL-10 in repeatedly restimulated Th2 cells. In Th1 cells, IL-10 expression is induced by IL-12, but the IL-10 gene lacks detectable histone acetylation. Accordingly, IL-10 expression in restimulated memory Th1 cells remains conditional on the presence of IL-12. This finding defines a potential anti-inflammatory role for IL-12 in Th1 recall responses. While in primary Th1 responses IL-12 is required to induce expression of the pro-inflammatory cytokine IFN-gamma, in secondary Th1 responses IFN-gamma re-expression is independent of IL-12, which still is able to induce expression of the anti-inflammatory cytokine IL-10.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17304625     DOI: 10.1002/eji.200636385

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  50 in total

Review 1.  Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.

Authors:  Huizhi Wang; Jonathan Brown; Michael Martin
Journal:  Cytokine       Date:  2010-11-23       Impact factor: 3.861

2.  CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation.

Authors:  S M Coomes; Y Kannan; V S Pelly; L J Entwistle; R Guidi; J Perez-Lloret; N Nikolov; W Müller; M S Wilson
Journal:  Mucosal Immunol       Date:  2016-05-11       Impact factor: 7.313

Review 3.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

Review 4.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 5.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 6.  Epigenetic regulation of cytokine gene expression in T lymphocytes.

Authors:  Choong-Gu Lee; Anupama Sahoo; Sin-Hyeog Im
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

Review 7.  Antigen-specific immunotherapy of autoimmune and allergic diseases.

Authors:  Catherine A Sabatos-Peyton; Johan Verhagen; David C Wraith
Journal:  Curr Opin Immunol       Date:  2010-09-17       Impact factor: 7.486

8.  Notch regulates IL-10 production by T helper 1 cells.

Authors:  Sascha Rutz; Marko Janke; Nadine Kassner; Thordis Hohnstein; Manuela Krueger; Alexander Scheffold
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

9.  Dual role of shikonin in early and late stages of collagen type II arthritis.

Authors:  Qiaomei Dai; Jianghong Fang; Feng-shan Zhang
Journal:  Mol Biol Rep       Date:  2008-09-10       Impact factor: 2.316

10.  Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose.

Authors:  Margarida Saraiva; Jillian R Christensen; Marc Veldhoen; Theresa L Murphy; Kenneth M Murphy; Anne O'Garra
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.